Arkansas Children's Hospital
Little Rock, Arkansas, 72207, United States
NCT Number: NCT00569855
Cardiopulmonary bypass is done with a machine that does the work of the heart and lungs during open-heart surgery. This study is to determine if intravenous (i.v.) phenoxybenzamine is safe. This drug lowers the blood pressure, making it easier for the cardiopulmonary bypass machine to deliver blood and oxygen to all of the organs and tissues.
Looking for future studies?
Notify MeUp to 18 year
All sexes
Interventional
Phase 2
Little Rock, Arkansas, 72207, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
0.125 to 1 mg/kg given i.v. over 15 to 45 minutes in preparation for cardiopulmonary bypass; may be continued at 0.125 mg/kg/day in ICU
Other names: Dibenzyline
Time frame: 72 hours postoperatively
Number of subjects who required Norepinephrine >0.1mcq/kg/min
University of Arkansas
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07232992
Open-heart Surgery, Serratus Posterior Superior Intercostal Plane Block (SPSIPB)
Bursa, Turkey (Türkiye)
View Trial DetailsNCT07259057
Erector Spinae Plane Block, Median Sternotomy
Trabzon, Turkey (Türkiye)
View Trial DetailsNCT07040735
Hemodynamics, Low-flow Anesthesia
Ankara, Turkey (Türkiye)
View Trial DetailsNCT03772990
Cardiac Surgery, Cardiopulmonary Bypass
Manama, Bahrain
View Trial Details